Lamivudine- Virocomb

Information About Lamivudine- Virocomb

About Lamivudine- Virocomb

The Medicine Brand Virocomb is manufactured by Ranbaxy Diagnostics and mainly contents the generic drug Lamivudine.

Pakaging

Active Ingredients For Lamivudine- Virocomb

Lamivudine 150mg Zidovudine 300mg

Diseases List For Which Lamivudine- Virocomb Is Prescribed

This Drug Is Prescribed For Portal systemic encephalopathy chronic or habitual constipation

Other Significations For Lamivudine- Virocomb

This Medication Lamivudine is an oral medication that is used for the treatment of infections with the human immunodeficiency HIV and hepatitis B viruses It is in a class of drugs called reverse transcriptase inhibitors which also includes zalcitabine Hivid zidovudine Retrovir didanosine Videx and stavudine Zerit During infection with HIV the HIV virus multiplies within the bodys cells The viruses then are released from the cells and spread throughout the body where they infect other cells In this manner HIV infection spreads to new uninfected cells that the body is continually producing and HIV infection is perpetuated When producing new viruses the HIV virus must manufacture new DNA for each virus Reverse transcriptase is the virus enzyme that forms this new DNA Lamivudine first is converted within the body to its active form lamivudine triphosphate This active form is similar to a chemical deoxycytidine triphosphate that is used by reverse transcriptase to make new DNA The reverse transcriptase uses lamivudine triphosphate instead of deoxycytidine triphosphate and the lamivudine triphosphate interferes with the reverse transcriptase Lamivudine does not kill existing HIV virus and it is not a cure for HIV Lamivudine was approved by the FDA in 1995

Precautions To Be Taken Before Lamivudine- Virocomb

Trimethoprimsulfamethoxazole Bactrim increases the concentration of lamivudine in the body

Major Conditions And Care

Pregnancy And Lamivudine- Virocomb

Can We Take Lamivudine- Virocomb During Pregnancy?

Pregnancy Class C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Lamivudine- Virocomb

Can We Use Lamivudine- Virocomb During Lactation

Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective

Side Effects Of Lamivudine- Virocomb

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Lamivudine- Virocomb